LIVN

LivaNova PLC

Price

$79.61

return (12m)

43.57%

p/e

22.82

p/bv

3.25

DIVIDEND YIELD

0.00%

LIVN price

LivaNova

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LIVN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.10%

3 months

7.87%

1 year

43.57%

2 years

64.69%

5 years

-3.40%

10 years

32.64%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LIVN

Valuation

P/E

22.82

Sector -0.16

Industry 2.77

P/BV

3.25

Sector 1.93

Industry 2.37

P/Revenue (PSR)

2.92

Sector 1.67

Industry 1.97

EV/EBITDA

92.88

Sector -55.30

Industry -73.25

EV/EBIT

158.66

Sector -488.87

Industry -73.47

P/EBITDA

20.65

Sector -178.48

Industry -262.99

P/EBIT

29.73

Sector -214.62

Industry -268.43

P/Total Assets

1.63

Sector 0.91

Industry 1.07

P/Net Current Assets

-14.81

Sector -24.70

Industry -5.25

P/Working Capital

13.54

Sector -5.32

Industry 3.11

EPS

3.43

Sector -0.79

Industry -0.61

BVPS

24.10

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

68.09%

Sector 48.28%

Industry 50.49%

EBITDA Margin

11.24%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

6.58%

Sector -62.93%

Industry -21.31%

Operating Margin

12.74%

Sector -23.12%

Industry -27.36%

Net Profit Margins

12.82%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.15

Sector 0.13

Industry 0.15

Profitability

ROE

14.23%

Sector -31.93%

Industry -27.86%

ROA

7.14%

Sector -28.25%

Industry -27.56%

ROIC

9.62%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.45

Sector 1.85

Industry 1.98

Net Debt / EBITDA

-5.16

Sector -42.46

Industry -72.45

Net Debt / EBIT

-8.82

Sector -37.26

Industry -7.11

Net Debt / Equity

-0.17

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.22

Sector -0.72

Industry 0.10

Equity/Assets

0.50

Sector 0.43

Industry 0.45

Liabilities/Assets

0.50

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

7.28%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF LivaNova ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$79.61

Fair Value

$43.13

Upside Return potential.

-45.83%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LIVN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LIVN LivaNova PLC	$79.61	40.93%	0.00%	22.82	3.25	14.23%	12.82%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.84	-2.34%	0.00%	11.50	1.42	12.32%	20.69%
DXCM DexCom Inc.	$90.49	18.47%	0.00%	34.80	13.27	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.23	11.53%	0.00%	51.94	4.86	9.36%	15.41%
BDX Becton Dickinson and Company	$189.33	-0.19%	2.21%	55.38	2.14	3.86%	6.30%
ALGN Align Technology Inc.	$157.75	11.11%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.75	20.18%	1.42%	49.15	11.14	22.66%	26.71%
SNN Smith & Nephew PLC	$28.91	-19.76%	2.63%	11.09	2.41	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LIVN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT LivaNova

LivaNova PLC

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

1993

Time since IPO - 33 years

4.000

Employees

LivaNova PLC (United States) is listed on the Nasdaq and has a market capitalization of $4.30 billion, with shareholders equity totaling $1.33 billion.

The company employs approximately 4.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, LivaNova PLC reported $1.47 billion in revenue, generating net income of $188.59 million.

Key financial metrics include a P/E ratio of 22.82, a price-to-book (P/B) ratio of 3.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LIVN.

Market cap

$4.30 billion

Net worth

$1.33 billion

$1,325,300,000.00

Assets

$2.64 billion

$2,640,900,000.00

Total Shares Outstanding

55.00 million

55,000,000

Average Daily Trading Volume

$702.97 Thousand

$702,970.92

Sector

Health

Industry

Medical Supplies and Equipment

LIVN

LIVN revenue and profits

Financial Results LIVN

DRAG THE FRAME TO SEE MORE DATA

LIVN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75